Janssen (OTC Products) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Buyout/​LBO
  • Financing Rounds
  • 1

Janssen (OTC Products) General Information

Description

A portfolio of over-the-counter products. The portfolio comprises products that are based on the anti-fungal substances econazole and ketoconazole and are used to treat common fungal infections of the skin.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Acquirer
Primary Office
  • Hochstrasse 201
  • 8200 Schaffhausen
  • Switzerland
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Janssen (OTC Products) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Janssen (OTC Products)‘s full profile, request access.

Request a free trial

Janssen (OTC Products) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Janssen (OTC Products)‘s full profile, request access.

Request a free trial